MedTrace Logo

Project Looking-Glass Evaluation

NCT06056063 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2025-09-15

No results posted yet for this study

Summary

Pilot study to validate the new design and workflow of Cone-Beam CT imaging for radiation therapy treatment simulation.

Conditions

  • Cone-Beam Computed Tomography

Interventions

DEVICE

Halcyon 4.0

This Halcyon 4.0 is a new imaging hardware recently developed by Varian and approved by the FDA.

Sponsors & Collaborators

  • Varian Medical Systems

    collaborator INDUSTRY

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Michelle Alonso-Basanta, MD, PhD · University of Pennsylvania

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-19
Primary Completion
2024-10-11
Completion
2026-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06056063 on ClinicalTrials.gov